<DOC>
	<DOCNO>NCT02607488</DOCNO>
	<brief_summary>Increasing rate obesity last decade lead grow demand bariatric surgery , may result decreased comorbidities improve patient outcome . Laparoscopic bariatric surgery several clinical benefit term improve quality analgesia , reduce pulmonary complication , enhance recovery bowel function , less immune suppression , shorten duration hospital stay open laparotomy . Some investigator report delayed return bowel function approximately two day laparoscopic bariatric surgery , despite occurred one day earlier open laparotomy . This potentially lengthen duration hospital stay bariatric procedure . With impede cost health care develop country , safely reduce length stay essential . Other investigator report early return bowel movement first postoperative day 65 % patient undergoing laparoscopic gastric bypass surgery due reduce morphine use implementation multimodal analgesia strategy include ketorolac , propoxyphene hydrochloride/acetaminophen . Lidocaine investigate several study use multi-modal management strategy reduce postoperative pain opioid use enhance recovery . A recent Cochrane review include 45 trial demonstrate systemic administration lidocaine associate reduced pain score 'early time point ' patient undergo laparoscopic abdominal surgery ( MD -1.14 , 95 % CI -1.51 -0.78 ; low-quality evidence ) , short time first flatus ( MD -5.49 hour , 95 % CI -7.97 -3.00 ; low-quality evidence ) first bowel movement ( MD -6.12 hour , 95 % CI -7.36 -4.89 ; low-quality evidence ) , less risk paralytic ileus ( risk ratio ( RR ) 0.38 , 95 % CI 0.15 0.99 ; low-quality evidence ) . However , evidence effect find lidocaine shorten time first defecation . This low-quality evidence may relate heterogeneity study respect optimal dose , time duration administration intravenous lidocaine .</brief_summary>
	<brief_title>Perioperative Systemic Lidocaine Enhanced Bowel Recovery After Bariatric Surgery</brief_title>
	<detailed_description>Hypothesis Recognizing need enhance bowel recovery patient undergo laparoscopic bariatric surgery , investigator hypothesize perioperative administration low rather high intravenous infusion rate lidocaine achieve early postoperative restoration bowel motility lower plasma level . Up best investigator ' knowledge study address effect perioperative administration systemic lidocaine postoperative recovery bowel function morbidly obese patient undergo laparoscopic bariatric procedure . Aim study This trial aim compare effect perioperative administration escalate dos intravenous lidocaine ( 1.0 , 1.5 2.0 mg/kg/h ) perioperative change hemodynamic , pain score , plasma lidocaine concentration , postoperative recovery bowel function , cumulative morphine use , hospital length stay , lidocaine related adverse effect obese patient undergo laparoscopic bariatric surgery general anesthesia . Randomization Five minute induction general anesthesia , participant allocate randomly four group draw sequentially number seal opaque envelope contain software-generated randomization code receive intravenous bolus 0.1 mL/kg either saline 0.9 % lidocaine 1.5 % solution follow continuous infusion 0.1 mL/kg/h Saline 0.9 % lidocaine 1 % , 1.5 % 2 % solution continue 24 hour surgery . All medication study protocol base dose body weight [ ideal body weight ( IBW ) + 0.4 × ( actual body weight−IBW ) ] . All study solution look identical prepared local pharmacy . All staff operate room unaware patient allocation group . Perioperative management An independent anesthesiologist involve study instruct participant preoperatively use patient control analgesia visual analogue scale ass severity postoperative pain ( 0 mm pain and100 mm bad imaginable pain ) . Anesthetic management standardize . Oral ranitidine 150 mg metoclopramide 10 mg administer night 60 min arrival operate room subcutaneous enoxaparin 60 mg administer 12 h schedule operation prophylaxis deep venous thrombosis . Participant 's monitoring include electrocardiography , non-invasive blood pressure , pulse oximetry , plethysmography variability index ( PVI ) capnography . Following pre-oxygenation , participant , anesthesia induce fentanyl 2-3 ug/kg propofol 1.5-2.5 mg/kg . Rocuronium 0.6 mg/kg administer facilitate tracheal intubation . Anesthesia initially maintain 0.7-1.2 minimum alveolar concentration ( MAC ) sevoflurane combination air ( 1 L/min ) oxygen ( 1 L/min ) mixture maintain mean arterial blood pressure ( MAP ) heart rate ( HR ) ≤20 % baseline value . Fentanyl 0.5 ug/kg increment administer MAP HR ≥20 % baseline value despite MAC sevoflurane ≥1.0 . Rocuronium 0.1 mg/kg , use maintain surgical relaxation . Lungs initially ventilate pressure-controlled mode deliver tidal volume 8 ml/kg predict body weight ( 0.919 × ( height cm − 152.4 ) + 45.5 woman 50 men ) I/E ratio 1:2 positive end-expiratory pressure ( PEEP ) 5 cmH2O . Respiratory rate adjust maintain end-tidal carbon dioxide tension ( ETCO2 ) 35 40 mm Hg . All operation perform surgeon . During CO2 pneumoperitoneum , intra-abdominal pressure maintain 12-14 mm Hg . Participants position change supine 40° reverse Trendelenburg position . During operation , intraoperative fluid management guide goal direct therapy algorithm use PVI guide fluid responsiveness . Hemodynamic control standardize accord investigator ' protocol . Hypotension ( define MAP value &lt; 25 % baseline value two consecutive reading within 3 min ) , respond decrease sevoflurane MAC 0.7 5 ml/kg mL Ringer lactate Acetate bolus 5 min , treat intravenous bolus ephedrine , 3 mg norepinephrine , 5 ug IV . Hypertension ( define &gt; 20 % increase mean baseline MAP ) treat deepen anesthesia administer dos fentanyl , labetalol , 20 mg. Tachycardia ( define &gt; 20 % increase mean baseline HR ) treat esmolol , 20 mg. Bradycardia ( HR &lt; 45 ) persist &gt; 2 min treat glycopyrrolate , 0.2 mg IV , boluses . Intravenous ondansetron , 4 mg IV , give participant prevention postoperative nausea vomit . Before wound closure , bupivacaine 0.25 % infiltrated portal , residual neuromuscular block antagonize neostigmine , 50 µg/kg IV , glycopyrrolate , 10 µg/kg IV . After complete surgery , sevoflurane discontinue infusion study medication continue 24 h wound closure . Times discontinuation sevoflurane eye opening , obey simple command ( e.g. , open mouth , squeeze hand ) tracheal extubation record . Postoperative analgesic regime standardize participant include 30 mg intravenous ketorolac every 6 h paracetamol 1 g IV every 6 h rescue dose intravenous meperidine 25 mg . Participants discharge post-anesthesia care unit modify Aldrete score level . Intravenous fluid run 40 mL/h night surgery discontinue 24 h surgery . Little attention pay urine output oliguria absence abnormal vital sign . Strict parameter fluid bolus night surgery place base hypotension tachycardia . Active bedside mobilisation enforce first time even surgery assist ambulation morning surgery least twice day . Criteria hospital discharge follow : absence nausea vomit last 24 h , return bowel function ( daily defecation ) toleration full diet , minimal pain ( VAS less 4 ) , afebrile surgically associate morbidity ( fever , wound dehiscence , wound infection , anastomotic leak , abscess ) . These variable record blind assessor allocation , every day 10:00 , 14:00 18:00 h. Patients ready discharge 14:00 h discharge follow morning . All drain remove discharge . Blindness All staff operate room unaware patient allocation group . Patients unaware allocation group . All study solution look identical prepared local pharmacy . Caregivers : An independent anesthesiologist involve study instruct patient preoperatively use patient control analgesia visual analogue scale ass severity postoperative pain ( 0 mm pain and100 mm bad imaginable pain ) give anesthetic instruct avoid use local anesthetic . An independent investigator involve assessment data participant blind group assignment . Statistical analysis : Data test normality use KolmogorovSmirnov test . Repeated-measures analysis variance use serial change continuous data different time administration study solution difference correct post-hoc Bonferroni correction test . Fisher 's exact test use categorical data . Kruskal-Wallis one-way ANOVA post-hoc Wilcoxon rank sum t-tests used comparison non-continuous data . Categorical data express number ( % ) , ordinal data express median [ range ] continuous data express mean ± SD . A value P &lt; 0.05 consider represent statistical significance . Power analysis sample size calculation : Based previous study , time return bowel movement laparoscopic bariatric surgery normally distribute mean 70 hour standard deviation 22 hour . An priori analysis indicate 45 patient group would sufficient detect 20 % reduction mean time return bowel movement , type I error 0.005 ( 0.05/10 possible comparison ) power 80 % . The investigator add 15 % patient account drop-outs study .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Obese patient body mass index equal great 35 kg/m2 . American Society Anesthesiologists ( ASA ) IIIII Patients schedule laparoscopic bariatric surgery general anesthesia History significant cardiac disease . History significant respiratory disease . History significant hepatic disease . History significant renal disease . History atrioventricular block grade II III . Long QT syndrome . Preexisting disorder gastrointestinal tract . Patients history alcohol drug abuse . Allergy amide local anesthetic . History epilepsy . Pregnancy . Patients receive cardiovascular medication . Patients receive steroid . Patients receive opioid analgesic medication within 24 h operation . Conversion laparoscopic open laparotomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Obese patient</keyword>
	<keyword>Undergoing bariatric surgery</keyword>
</DOC>